Purchases and Sales Made in Q1 2023 in Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL) during Q1 2023. The information is specifically focused on institutions that hold shares of AbCellera Biologics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-198K- 20.65% |
$1.45M - $2.22M
|
762K
$2.16M
|
|
|
May 11, 2023
Q1 2023
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-225K- 97.37% |
$1.64M - $2.51M
|
6.07K
$17.2K
|
|
|
May 15, 2023
Q1 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-394K- 41.26% |
$2.88M - $4.4M
|
561K
$1.59M
|
|
|
May 15, 2023
Q1 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-979K- 40.0% |
$7.16M - $10.9M
|
1.47M
$4.16M
|